Jpmorgan Chase & Co »

Acorda Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Acorda Therapeutics (ACOR) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Acorda Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acorda Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acorda Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $44 3 14.67
2023-09-30 $29 2 14.50
2023-06-30 $13 1 13.00